Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation

Cell Transplantation(2025)10.1177/09636897241309412Source: DataRank Database

Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation is a research paper published in Cell Transplantation (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.06)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jeannette Stratton,Mohamed A. El-Shahawy,Elena Forouhar,Alice Peng ORCID,Gagandeep Singh ORCID

Live enrichment

PubMed:39780302 PMC:PMC11713960 OpenAlex:https://openalex.org/W4406191066

National Institutes of Health,National Center for Research Resources, National Institute of Diabetes and Kidney Diseases

Grant: U42-RR16607

Juvenile Diabetes Research Foundation International

Grant: 31-2008-616

NCRR NIH HHS

Grant: U42 RR016607

National Institutes of Health

Grant: 3U42RR016607-01S1

ISLET-CELL RESOURCES CTR OF SOUTHERN CALIFORNIA

FWCI

3.06

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1177/09636897241309412

publisherhttps://doi.org/10.1177/09636897241309412

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/09636897241309412

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/09636897241309412

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39780302

Fields of Study

Pancreatic function and diabetesImmune Cell Function and InteractionPolyomavirus and related diseases03 medical and health sciences0302 clinical medicine

MeSH Terms

AdultAge FactorsAgedFemaleHumansImmunosuppressive AgentsMaleMiddle AgedSkin NeoplasmsBody Mass IndexIslets of Langerhans TransplantationTacrolimusSirolimus

Keywords

TacrolimusMedicineSirolimusBody mass indexSkin cancerImmunosuppressive drugImmunosuppressionGastroenterologyInternal medicineOdds ratioCancerUrologyTransplantationOncologyMelanomaSquamous cell carcinomaBasal Cell CarcinomaIslet Cell TransplantationIslet Graft DysfunctionMaleAdultSkin NeoplasmsRIslets of Langerhans TransplantationAge FactorsMiddle AgedHumansOriginal ArticleFemaleImmunosuppressive AgentsAged

Sustainable Development Goals

SDG 0: Good health and well-being

Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)